A Step-by-Step Problem-Solving Strategy in a Patient With Heart Failure and Cerebral Aneurysm.

Abstract

Left ventricular assist device implantation is an established treatment for patients with end-stage heart failure. The HeartMate 3 (Abbott Laboratories, Abbott Park, IL) is a continuous-flow centrifugal pump, recently introduced in the clinic, that has shown greater hemocompatibility compared with similar devices of previous generations. Nevertheless, anticoagulation is still required after HeartMate 3 implant to avoid pump dysfunction. Hereafter, we describe the case of a patient candidate to left ventricular assist device implantation for end-stage heart failure presenting a concomitant cerebrovascular lesion, accidentally found during preoperative assessment, that would have contraindicated the procedure (for the prohibitive risk of cerebral hemorrhage), unless a step by step problem-solving approach was adopted.

• Authors: Elena Rossi, Assunta Fabozzo, Nicola Pradegan, Chiara Tessari, Joseph Domenico Gabrieli, Francesco Causin, Vincenzo Tarzia, Tomaso Bottio, Gino Gerosa
• Journal: The Annals of thoracic surgery (Ann Thorac Surg) Vol. 109 Issue 4 Pg. e285-e287 (04 2020) ISSN: 1552-6259 [Electronic] Netherlands
• PMID: 31473176 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Topics

• Contraindications, Procedure
• Heart Failure (complications, surgery)
• Heart-Assist Devices
• Humans
• Intracranial Aneurysm (complications)
• Male
• Middle Aged
• Postoperative Complications (etiology, prevention & control)
• Prosthesis Implantation (adverse effects, methods)